PORTFOLIO

PORTFOLIO COMPANIES

Glytech, Inc.

  • CEO:
    Hiroaki Asai

URL:http://www.glytech.jp/jp/

COMPANY PROFILE

Developing exceptionally pure biopharmaceuticals by synthesizing and modifying the glycopeptide and glycoproteins.

GlyTech is a pioneer of glycoscience/glycotechnology. They have established the large-scale manufacturing process for highly purified and characterized N-glycans as well as the chemical synthesis of glycosylated compounds, especially for glycopeptides and glycoproteins.

GlyTech’s technologies can contribute to develop safer and cost-effective biopharmaceuticals. GlyTech expects to play a significant role in developing innovative bio-betters with high functionalities.

COMPANY STORY

Origin

Glytech was founded with the goal of producing highly pure sugar chains in humans at the large scale for bio-industry. The technology is based on the research results from the founder's previous job at Otsuka Chemical Co., Ltd. and a collaborative research with Professor Yasuhiro Kajiwara of Osaka University.

Strength

Commercialized drug discovery screening system and drug substance through a precise and rapid chemical synthesis of biopharmaceutical drugs and compounds such as glycopeptide and glycoprotein.

UTEC value up

UTEC leverages its strong network in life sciences ecosystem to introduce several partners and experts to Glytech. UTEC supported SeriesA fund-raising.
  • Attachment of Glycans to Peptides/Proteins Via Solid or Solution Phase Synthesis.

  • Laboratory

RELATED NEWS